LCKLSL
LCKLSL is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL also inhibits the generation of plasmin and has anti-angiogenic roles.
Catalog Number | R1923 |
Research Area | Cardiovascular Disease |
Molecular Formula | C30H57N7O8S |
CAS# | 533902-29-3 |
Purity | >95% |
Size | Inquiry |
Supplier Page | https://www.creative-peptides.com/product/lcklsl-item-r1923-39640.html |